title: Menstrual suppression with the levonorgestrel intrauterine system in girls with developmental delay.
abstract: OBJECTIVE
  To describe the experiences of 21 girls with developmental delay accompanied by multiple other medical problems, seen over a 3-year interval, who underwent insertion of the levonorgestrel intrauterine system (LNG-IUS) for menstrual suppression.
  
  
  METHODS
  Retrospective chart review.
  
  
  METHODS
  A referral pediatric and adolescent gynecology clinic within a tertiary care medical center with referrals from community pediatricians, pediatric subspecialists including developmental and behavioral pediatricians, community gynecologists, and adolescent medicine specialists.
  
  
  METHODS
  Adolescents and young women with developmental delay and multiple comorbid conditions who were seen for consultation with their families requesting menstrual suppression.
  
  
  METHODS
  Participants were offered hormonal options, for menstrual suppression including the LNG-IUS.
  
  
  METHODS
  Satisfaction with menstrual suppression among families electing the LNG-IUS.
  
  
  RESULTS
  Adolescents and young women seen at CCHMC with developmental delay and multiple comorbid conditions with requests for menstrual suppression were offered hormonal options, including the LNG-IUS. Twenty-one families chose this option. Fifteen of 21 girls had previously used hormonal menstrual suppression. General anesthesia was required for 20 of 21 insertions, and 9 of 20 of these insertions were combined with other surgical procedures. There were no unsuccessful insertions or major complications. Mean duration of follow-up was 11 months, and families were satisfied with this option for menstrual suppression. There was 1 request for removal.
  
  
  CONCLUSIONS
  LNG-IUS for menstrual suppression, in girls with developmental delay and multiple comorbid medical conditions for which amenorrhea is desirable and therapeutic, appears promising.
authors: Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA. Paula.Hillard@stanford.edu
authors: Paula J Adams
authors: PJ
authors: Hillard
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D015897:Comorbidity; D002658:Developmental Disabilities; D005260:Female; D006801:Humans; D007436:Intrauterine Devices, Medicated; D016912:Levonorgestrel / Q000008:administration & dosage*; D008598:Menstruation / Q000187:drug effects*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D016912:Levonorgestrel